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Abstract
Background: Shewanella oneidensis MR-1 uses several electron acceptors to support anaerobic
respiration including insoluble species such as iron(III) and manganese(IV) oxides, and soluble
species such as nitrate, fumarate, dimethylsulfoxide and many others. MR-1 has complex branched
electron transport chains that include components in the cytoplasmic membrane, periplasm, and
outer membrane (OM). Previous studies have implicated a role for anaerobically upregulated OM
electron transport components in the use of insoluble electron acceptors, and have suggested that
other OM components may also contribute to insoluble electron acceptor use. In this study, the
role for an anaerobically upregulated 35-kDa OM protein (Omp35) in the use of anaerobic electron
acceptors was explored.
Results: Omp35 was purified from the OM of anaerobically grown cells, the gene encoding
Omp35 was identified, and an omp35 null mutant (OMP35-1) was isolated and characterized.
Although OMP35-1 grew on all electron acceptors tested, a significant lag was seen when grown
on fumarate, nitrate, and Fe(III). Complementation studies confirmed that the phenotype of
OMP35-1 was due to the loss of Omp35. Despite its requirement for wild-type rates of electron
acceptor use, analysis of Omp35 protein and predicted sequence did not identify any electron
transport moieties or predicted motifs. OMP35-1 had normal levels and distribution of known
electron transport components including quinones, cytochromes, and fumarate reductase. Omp35
is related to putative porins from MR-1 and S. frigidimarina as well as to the PorA porin from
Neisseria meningitidis. Subcellular fraction analysis confirmed that Omp35 is an OM protein. The
seven-fold anaerobic upregulation of Omp35 is mediated post-transcriptionally.
Conclusion:  Omp35 is a putative porin in the OM of MR-1 that is markedly upregulated
anaerobically by a post-transcriptional mechanism. Omp35 is required for normal rates of growth
on Fe(III), fumarate, and nitrate, but its absence has no effect on the use of other electron
acceptors. Omp35 does not contain obvious electron transport moieties, and its absence does not
alter the amounts or distribution of other known electron transport components including
quinones and cytochromes. The effects of Omp35 on anaerobic electron acceptor use are
therefore likely indirect. The results demonstrate the ability of non-electron transport proteins to
influence anaerobic respiratory phenotypes.
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Background
Shewanella oneidensis (formerly  putrefaciens) MR-1 is a
Gram-negative bacterium that can use a wide variety of
terminal electron acceptors for anaerobic respiration
including insoluble manganese (Mn) and iron (Fe) oxides
[1-4]. Some electron transport components are common
to the use of multiple electron acceptors. For example,
both menaquinone and a 21-kDa tetraheme cytochrome
c (CymA) are required for the use of fumarate, nitrate,
Mn(IV), and Fe(III) [4-6]. Other components are specific
for individual electron acceptors, including a periplasmic
cytochrome that serves as the fumarate reductase [7] and
the cytochrome OmcA which has a role in Mn(IV) reduc-
tion [8]. However, many components that influence or
participate in electron acceptor use in MR-1 remain
unidentified.
Outer membrane (OM) components could be important
for the ability of MR-1 to reduce insoluble metal oxides.
For example, the OM cytochromes OmcA and OmcB play
a role in Mn(IV) reduction but are not essential for Fe(III)
reduction [8,9]. The Mn(IV) and Fe(III) reductases in MR-
1 may be distinct [9,10], and various studies suggest the
presence of Fe(III) reductase in the OM [11-13]. Insights
are needed into other OM components that could have
roles in metal reduction.
Since metal reduction is predominant under anaerobic
conditions [2,13,14], components which are upregulated
under anaerobic conditions could represent candidates
with potential roles in these reductive processes. In this
manuscript, a 35-kDa OM protein (Omp35) that is upreg-
ulated under anaerobic conditions was identified and
characterized. Although Omp35 lacks obvious electron
transport moieties, a null mutant lacking Omp35 exhib-
ited significant lags during growth on three anaerobic
electron acceptors: fumarate, nitrate, and Fe(III).
Results
Purification of Omp35
While numerous procedures were used to attempt purifi-
cation of Omp35, the two protocols described in the
methods section resulted in a significant purification with
Omp35 being the predominant protein (data not shown).
The N-terminal sequence of Omp35 (EGPSFYGRLELALT-
NTETGA) aligned perfectly to an open reading frame
(ORF) in the MR-1 genomic sequence at locus SO3896 at
the coordinates 4042055-4043161 (The Institute for
Genomic Research [TIGR]). This 1158-bp ORF encoded a
protein with a predicted molecular mass of 39,900 Da.
However, the first 23 amino acids resemble a hydropho-
bic leader sequence. Starting with the N-terminal protein
sequence, the predicted mass of the mature protein is
37,600 kDa, which is consistent with the size seen on
SDS-PAGE (35.0 ± 0.5 kDa). BLAST analysis identified the
strongest alignment of Omp35 to a hypothetical OM
porin (IfcO) from S. frigidimarina (emb CAB37061.1;
smallest sum probability (P) value of 1.9 × 10-85; 46%
identity and 61% similarity). The ifcO gene in S. frigidima-
rina is located on the opposite strand upstream of an iron-
induced flavocytochrome Ifc3 [15].
Expression and in vivo role of Omp35
Identification of the omp35 gene allowed for the develop-
ment of an Omp35-specific antibody and the generation
of an insertional mutant in which part of omp35  was
replaced by a kanamycin-resistance (Kmr) casette. This
strain, OMP35-1, met all criteria expected for an omp35
null mutant: (i) it lacked the expected 1.7-kb wild-type
PCR product for omp35; (ii) it was positive for a 3.4-kb
PCR product consistent with Kmr-interrupted omp35 (Fig.
1); (iii) it was negative for a PCR product using primers
specific to the cat gene of pEP185.2 (Fig. 1); and (iv) it
grew in the presence of kanamycin but not in the presence
of chloramphenicol. The lack of the cat gene and sensitiv-
ity to chloramphenicol are consistent with a double-cross-
over gene replacement.
Western blots confirmed the absence of Omp35 in all sub-
cellular fractions of OMP35-1, whereas Omp35 was read-
ily detected in the OM and intermediate density
membrane (IM) fractions of MR-1 (Fig. 2). The IM closely
resembles the OM, except for a buoyant density between
that of the cytoplasmic membrane (CM) and OM [16].
Omp35 was not detected in CM or soluble fractions of
MR-1 (Fig. 2). This subcellular localization is consistent
with its purification from the OM. The levels of Omp35 in
OM fractions from the OM cytochrome mutants OMCA1
(∆omcA) and OMCB1 (∆omcB) [8] were the same as those
for MR-1 (data not shown).
Western blots confirmed that Omp35 is significantly
upregulated under anaerobic conditions, with levels more
than 7-fold higher in fumarate-grown cells compared to
aerobically-grown cells (Fig. 3A,3B). This is not the result
of transcriptional regulation because the levels of omp35
transcript were statistically similar in aerobically- and
fumarate-grown MR-1 (Fig. 3C,3D). Levels of Omp35
protein in the OM of the etrA mutant ETRA-153 [17] were
similar to the levels found in the OM of MR-1 suggesting
that EtrA does not significantly regulate Omp35 (data not
shown).
The ability of wild-type omp35 to complement OMP35-1
was examined. Two constructs (pBComp218 and
pBComp411) containing omp35 plus 218 and 411 bp of
upstream DNA, respectively, in the vector pBCSK were
introduced into OMP35-1. Each insert was tested in both
orientations; the forward (F) is in frame with the lacZ pro-
moter of the vector, whereas the reverse (R) is not.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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Western blots showed that all four constructs
(pBComp218F, pBComp218R, pBComp411F,
pBComp411R) restored Omp35 to OMP35-1 at levels
that were greater than those of wild-type (Fig. 4).
The potential role of Omp35 in anaerobic respiration was
assessed by a comparison of the relative abilities of MR-1
and OMP35-1 to grow on and reduce various electron
acceptors. The maximal growth yields of OMP35-1 were
essentially the same as those for MR-1, with no apparent
growth lags on 20 mM TMAO, 5 mM DMSO, 10 mM thi-
osulfate, or O2 as terminal electron acceptors (data not
shown). OMP35-1 also reduced 5 mM δMnO2 and AQDS
at rates similar to those of MR-1 (data not shown). How-
ever, there was a distinctive lag in the onset of growth of
OMP35-1 on 20 mM fumarate, 2 mM nitrate, and 10 mM
Fe(III) citrate (Figs. 5,6), and in the reduction of Fe(III)
citrate and 2 mM αFeOOH (Figs. 6,7). The rates of reduc-
tion of nitrate and nitrite by OMP35-1 were also slower
than those of MR-1 (not shown), corresponding to the
delayed growth on nitrate. The lag on fumarate was the
most pronounced with MR-1(pBCSK) reaching maximal
growth at 1 day, while OMP35-1(pBCSK) showed no
growth until day 3 (Fig. 5A). On nitrate, OMP35-1 took
one day longer than MR-1 to attain maximal growth (Fig.
5B). The growth of OMP35-1(pBCSK) on Fe(III) citrate
lagged behind that of MR-1(pBCSK) for the first 12 hrs
(Fig. 6B).
Three of the four complementing omp35  plasmids
restored the growth of OMP35-1 on fumarate to rates that
were indistinguishable from those of wild-type (Fig. 5A).
The growth rate of OMP35-1(pBComp218R) was less
than that of MR-1, but was much closer to MR-1 than to
OMP35-1 (Fig. 5A). One of the constructs
(pBComp218F) restored nitrate reduction and growth to
wild-type levels, whereas the other three constructs exhib-
ited a lag similar to OMP35-1 (Fig. 5B). However, the final
growth yields on nitrate were greater for the various com-
plements than for OMP35-1 (Fig. 5B). Similar to the
nitrate results, growth on and reduction of Fe(III) citrate
was near wild-type for OMP35-1(pBComp218F) (Fig. 6),
whereas the others lagged behind wild-type at 12 hrs (Fig.
Colony PCR reactions with primers specific for the omp35  gene or the chloramphenicol acetyltransferase gene (cat)  from pEP185.2 Figure 1
Colony PCR reactions with primers specific for the 
omp35 gene or the chloramphenicol acetyltrans-
ferase gene (cat) from pEP185.2. Lanes 1 and 2 are reac-
tions with omp35 primers O1 and O2 (see Table 2) and lanes 
3–5 are reactions with cat primers C1 and C2 (see Table 2). 
The templates for PCR were as follows: lanes 1 and 3, MR-1; 
lanes 2 and 4, OMP35-1; lane 5, pDSEPomp35. The sizes of 
the DNA markers (lane M) in kilobases are indicated on the 
left.
Western blot of subcellular fractions of MR-1 and OMP35-1  with an antibody specific for Omp35 Figure 2
Western blot of subcellular fractions of MR-1 and 
OMP35-1 with an antibody specific for Omp35. The 
lanes were loaded with 20 ng protein from each subcellular 
fraction; cytoplasmic membrane (CM), intermediate mem-
brane (IM), outer membrane (OM), and soluble fraction (sol-
uble). Fractions were isolated in duplicate from cells grown 
anaerobically with fumarate as the electron acceptor. The 
results shown are representative.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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6B). OMP35-1(pBCSK) could reduce insoluble αFeOOH,
but it was significantly slower than MR-1(pBCSK) (Fig. 7).
All four constructs partially restored αFeOOH reduction
to levels that were between those of wild-type and
OMP35-1 (Fig. 7). Both R constructs exhibited less Fe(II)
accumulation than the corresponding F constructs (Fig.
7), which could indicate some control of expression of the
F constructs by the lacZ promoter of pBCSK.
Cell surface exposure of Omp35
To determine the potential cell surface exposure of
Omp35, proteinase K susceptibility experiments were
conducted with anaerobically grown MR-1 cells and com-
pared to control cells that were exposed to buffer. The pro-
teinase K-to-control ratio for the periplasmic fumarate
reductase was near unity, i.e. the same in proteinase K and
buffer-treated cells (Fig. 8), indicating that proteinase K
did not compromise the integrity of the OM. The ratio for
Omp35 was also near unity (Fig. 8) indicating that
Omp35 is not significantly exposed to proteinase K at the
cell surface. However, proteinase K treatment of either
purified OM (Fig. 8) or OM solubilized with 0.2% Z3-12
(data not shown) from fumarate-grown MR-1 resulted in
complete degradation of Omp35. Thus, proteinase K can
completely degrade Omp35 if given sufficient access. To
confirm that the proteinase K was active in the whole cell
experiments, the surface-exposed outer membrane cyto-
chrome OmcA was substantially degraded by proteinase K
(Fig. 8) in agreement with previous findings [18].
Possible roles of Omp35 in cells
Since the absence of Omp35 caused significant lags in the
use of some, but not all, electron acceptors, Omp35 might
have either direct or indirect roles in electron transport.
Relative levels of Omp35 protein (A, B) and omp35 transcript (C, D) in aerobically-grown versus fumarate-grown MR-1 Figure 3
Relative levels of Omp35 protein (A, B) and omp35 transcript (C, D) in aerobically-grown versus fumarate-
grown MR-1. A, B: Omp35 protein was detected by western blot of whole cells using an antibody specific for Omp35. An 
example of two dilutions of a representative experiment are shown in panel A, and the quantitative results from densitometric 
analysis of western blots from three independent experiments (mean ± S.D.) are shown in panel B. *, statistically different from 
aerobic to P ≤ 0.001. C, D: Transcript was determined by RNase protection using an antisense probe specific for the omp35 
transcript. The data for three independent experiments are shown in panel C, and the quantitative results from densitometric 
analysis of the RPA blots (mean ± S.D.) are shown in panel D. For each experiment, dilutions of each sample were analyzed to 
ensure linearity of signal intensity.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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While its OM location could make sense for a direct role
in Fe(III) reduction, it is not clear why this would impact
the use of soluble electron acceptors such as fumarate and
nitrate whose terminal reductases are periplasmic
(fumarate) [7,19] or likely periplasmic (nitrate). The
effects on soluble electron acceptors might imply indirect
effects which alter the synthesis or distribution of other
electron transport components.
To examine possible indirect effects, the content and dis-
tribution of electron transport components in fumarate-
grown OMP35-1 was compared to that of MR-1. Protein-
and heme-stained SDS-PAGE patterns of subcellular frac-
tions were similar for the two strains (data not shown).
Cytochrome spectra of the subcellular fractions indicated
that the cytochrome content and distribution of OMP35-
1 were similar to MR-1 (data not shown). Western blot-
ting of membrane and soluble fractions showed no signif-
icant differences between MR-1 and OMP35-1 in the
content or distribution of the OM cytochromes OmcA
and OmcB, the OM protein MtrB, and the periplasmic
fumarate reductase (Fcc3) (data not shown).
Menaquinone is an important electron transport compo-
nent required for the reduction of fumarate, nitrate,
Fe(III), and Mn(IV) [6]. OMP35-1 displayed a delayed
phenotype on three of these. However, the levels of
menaquinone, methylmenaquinone, and ubiquinones
were similar in MR-1, MR-1(pBCSK), OMP35-1, and
OMP35-1(pBCSK) (data not shown). Analysis of Omp35
protein in the OM of the menaquinone-minus mutant
CMA-1 [6] indicated that the levels were similar to those
found in the OM of MR-1 (data not shown). Therefore,
OMP35-1 contains a normal complement of quinones,
Western blot of lysed whole cells with an antibody specific  for Omp35 Figure 4
Western blot of lysed whole cells with an antibody 
specific for Omp35. Each lane was loaded with equivalent 
wet cell pellet weight (30 µg). The strains carrying the vari-
ous plasmids are indicated above each lane. This blot is rep-
resentative of duplicate experiments. The bars and numbers 
at the right indicate the migration and mass of the protein 
standards. The results shown are for aerobically grown cells. 
Analogous results were obtained with fumarate-grown cells 
(not shown).
Anaerobic growth of various strains on fumarate (A) and  nitrate (B) Figure 5
Anaerobic growth of various strains on fumarate (A) 
and nitrate (B). Values represent mean ± high/low for two 
parallel but independent experiments for each strain.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
Page 6 of 16
(page number not for citation purposes)
and the absence of menaquinone and methylmenaqui-
none does not affect the level of Omp35 protein in CMA-
1.
It was noted during the purification of Omp35 that frac-
tions containing Omp35 had a yellow color. Because fla-
vins (FAD and FMN) have a yellow color and are electron
transfer cofactors of some proteins, the possibility that
Omp35 is a flavoprotein was explored. To detect the
possible presence of either FAD or FMN in partially puri-
fied or purified fractions containing Omp35, several
techniques were used including fluorescence spectros-
copy, thin layer chromatography (TLC), and UV-visible
spectral analysis. All three detected the flavin standards
(FAD and FMN) but all three failed to detect any flavin
moiety in the yellow fractions containing Omp35. The
lower limits of detection of the standards were 0.1 nmol
and 2.5–5 pmol for TLC and fluorescence spectroscopy,
respectively. Attempts to remove non-covalently bound
flavin (boiling, trichloroacetic acid precipitation, and
chloroform extraction) and UV-visible spectra of non-
treated proteins also failed to detect any flavin. The sum
total of procedures should have been able to detect either
covalently or noncovalently bound flavin. Spectral analy-
sis of Omp35 fractions was also negative for heme as were
heme-stained SDS-PAGE gels. Motif searching of the
Omp35 sequence resulted in no matches for heme- or fla-
vin-binding motifs or other motifs suggestive of electron
transport proteins.
A small nonproteinaceous compound is apparently
excreted from MR-1 that has the ability to restore AQDS
reduction to a menaquinone-minus mutant [20]. This
compound is not menaquinone, but is apparently redox-
active and has a yellow-orange color [20]. Studies were
Anaerobic reduction (A) and growth (B) on Fe(III) citrate by  various strains Figure 6
Anaerobic reduction (A) and growth (B) on Fe(III) 
citrate by various strains. One representative experiment 
from two independent experiments is shown.
Anaerobic reduction of αFeOOH by various strains Figure 7
Anaerobic reduction of αFeOOH by various strains. 
Values represent mean ± high/low for two parallel but inde-
pendent experiments for each strain.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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done to explore the possibility that Omp35 may have a
role in the secretion of this compound. If true, the yellow
color associated with Omp35 could conceivably be due to
an affinity between this compound and Omp35. On sep-
arate plates, MR-1 and OMP35-1 were streaked adjacent
to the menaquinone-minus mutant CMA-1 in a triangular
pattern as done by Newman and Kolter [20]. Both MR-1
and OMP35-1 restored the ability of CMA-1 to reduce
AQDS and Fe(III) (not shown). This indicates that
OMP35-1 retained the ability to excrete this compound
and that Omp35 is not necessary for its secretion.
Discussion
The 7-fold upregulation of Omp35 in fumarate-grown
versus aerobically-grown MR-1 (Fig. 3A) is similar to the
7-fold anaerobic upregulation of the OM cytochrome
OmcA [16]. This upregulation suggests an important func-
tion under anaerobic conditions. A role for OmcA is lim-
ited to Mn(IV) reduction [8], whereas the absence of
Omp35 resulted in significant lags in growth on fumarate,
nitrate, and Fe(III). Several other proteins in MR-1 are also
increased under anaerobic conditions including the OM
cytochrome OmcB, and the activities for Fe(III), nitrate
and fumarate reductases, and formate dehydrogenase
[8,13,19]. The mechanisms responsible for these anaero-
bic upregulations have not been identified in MR-1. While
the transcriptional regulator EtrA has a partial role in
upregulating fumarate and nitrate reductase [17], it has no
effect on levels of OM cytochromes or Omp35. This coin-
cides with the observation that the upregulation of
Omp35 is not transcriptional (Fig. 3). The anaerobic
induction of OM proteins with resulting effects on
anaerobic electron transport have been reported in other
species. For example, a major OM protein (AniA) which
resembles copper-containing nitrite reductase is
anaerobically induced in Neisseria gonorrhoeae [21]. How-
ever, the aniA mRNA in N. gonorrhoeae is only expressed
under anaerobic conditions, with a role for Fnr and NarP
as transcriptional regulators [21].
Regarding the post-transcriptional upregulation of
Omp35 under anaerobic conditions (Fig. 3), possible
control mechanisms include factors that affect translation
efficiency, such as mRNA binding proteins or mRNA sec-
ondary structure elements that repress/activate translation
[22-24]. Translational regulation of proteins that are
induced anaerobically has been reported. The level of eth-
anol dehydrogenase (AdhE) activity is 10-fold higher in
fermentatively-grown versus aerobically-grown E. coli K-
12, and the translation of adhE mRNA is regulated by RNA
secondary structure changes that block the RNA polymer-
ase binding site [25]. Pseudoazurin, a periplasmic shuttle
protein in Thiosphaera pantotropha, is expressed anaerobi-
cally during nitrification and is regulated by changes in
RNA secondary structure [26].
The proteinase K experiments indicated that Omp35 is
not significantly exposed on the cell surface. Proteinase K
was chosen for these studies because it cleaves on the car-
boxyl side of a variety of amino acids including aliphatic,
aromatic, and hydrophobic residues, and because it com-
pletely degraded Omp35 when given adequate access to
the protein in purified OM fragments (Fig. 8). This is con-
sistent with the Omp35 sequence, which indicates that
68% of the Omp35 residues are possible proteinase K
cleavage sites. While proteinase K-resistant residues of
Omp35 could be exposed on the cell surface in small
loops, sizable extracellular loops are not likely because the
longest stretch of proteinase K-resistant residues in
Omp35 is four. Since Omp35 is not significantly exposed
on the cell surface, it is also hard to envision a direct role
in cell attachment or adhesion. Even so, while proteins
that influence adhesion to insoluble Fe(III) oxides could
be important [12], it is not clear why this would affect
growth on nitrate and fumarate.
The significant growth lags observed with OMP35-1 on
fumarate, nitrate, and Fe(III) indicate that Omp35 is
required for optimal growth rates under these conditions.
While complementation of OMP35-1 with pBComp218F
restored wild-type growth on fumarate, nitrate, and
Fe(III), the other omp35 constructs varied in their ability
The effect of proteinase K on MR-1 proteins OmcA, fuma- rate reductase (FR), and Omp35 Figure 8
The effect of proteinase K on MR-1 proteins OmcA, 
fumarate reductase (FR), and Omp35. Either fumarate-
grown whole cells (WC) or purified outer membrane (OM) 
fractions isolated from fumarate-grown MR-1 were treated 
with proteinase K. Results of duplicate experiments are 
expressed as the ratio of band intensity with proteinase K vs. 
protease-free control. *, statistically significant from FR con-
trol to P ≤ 0.006.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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to restore electron acceptor use (Figs. 5,6,7), even though
all restored Omp35 protein (Fig. 4). While expression of
the forward constructs could be influenced by the lacZ
promoter of the vector, it is unclear why OMP35-
1(pBComp411F) was slower on nitrate and Fe(III) than
was OMP35-1(pBComp218F) despite ~200 bp of addi-
tional upstream DNA. One possibility is that the extra
upstream DNA in pBComp411F might have reduced
control of the lacZ promoter on omp35 expression. If RNA
secondary structure controls translation of omp35, non-
optimal levels of transcript could influence protein levels.
However, Omp35 levels in all four constructs were quite
similar and about two-fold higher than those in MR-1
based on NIH image analysis of the western blots (Fig. 4).
Since the pBComp218F construct was able to fully com-
plement OMP35-1, elevation of Omp35 levels above
those found in MR-1 is not necessarily problematic.
However, closer examination indicated that OMP35-
1(pBComp218F) contained 20–30% less Omp35 than
the other three complements. It is unclear if such minor
differences influence the phenotypes, but it is possible
that the cells are sensitive to small variations in Omp35
content.
The mechanism by which Omp35 affects growth rates on
only some electron acceptors is not clear. Omp35 does
not contain detectable heme or flavin, and sequence anal-
ysis does not reveal any sites suggestive of iron-sulfur
centers, heme- or flavin-binding sites, molybdopterin-
binding sites, or other redox-active moieties. Omp35 is
therefore not likely to be an electron transport protein.
However, motif searching does have limitations. Some
motifs can be quite variable among organisms and the
motifs are based on most likely consensus domains
derived from a limited number of proteins. Therefore,
while Omp35 is likely not an electron transport protein,
this possibility cannot be completely dismissed. However,
such a role would not make sense for fumarate and nitrate
given that these terminal reductases are periplasmic in
MR-1. However, the size of Omp35 is consistent with the
size range typical for porins [27], and sequence align-
ments predict that Omp35 is likely a porin (Fig. 9).
Omp35 aligned most prominently to a hypothetical pro-
tein (IfcO) in S. frigidimarina NCIMB400 (46.3% identity,
61.2% homology) (Fig. 9). IfcO is located upstream of
ifcA (a gene encoding an iron-induced flavocytochrome
Ifc3) [15]. IfcO displays 20% identity to a cation-selective
porin from Neisseria meningitidis [15]. The genes sur-
rounding omp35 in MR-1 and ifcO in S. frigidimarina are
quite different, suggesting that there could be differences
in regulation and/or function. Omp35 also aligned to two
putative porins at loci SO1420 and SO1557 in the MR-1
genome (31.4 and 23.0% identity, and 45.0 and 39.3%
homology, respectively) (Fig. 9) and to the porin PorA
[28] from N. meningitidis (20.6% identity, 35.5% homol-
ogy) (Fig. 9). The sequence homologies are consistent
with the presence of conserved membrane core domains
and variable loops typical of porins [29,30]. The extent of
sequence identity and homology is also typical for that
seen with porins across other species.
It is, however, not clear how a porin role for Omp35
relates to the observed electron acceptor phenotype of
OMP35-1. If Omp35 is needed for diffusion of electron
acceptors across the OM, one might have expected its
absence to slow the rate of entry of all soluble electron
acceptors including fumarate, nitrate, TMAO, DMSO,
nitrite, and thiosulfate. All of these have molecular
weights that range from 50–120 Da, well below the exclu-
sion limit for many porins (<600 Da) [31,32]. While
some porins can discriminate between substrates based
on their charge [31,33], the electron acceptors affected in
OMP35-1 have different charge characteristics:
[fumarate2- at pH 7], nitrate [NO3
-], and Fe(III) citrate or
αFeOOH [neutral overall]. The reduction of thiosulfate
[S2O3
2-] and TMAO and DMSO [neutral] were not affected
in OMP35-1. Since αFeOOH is insoluble and too large to
cross the OM, a porin would have no role in αFeOOH dif-
fusion. While the loss of a porin might impair entry of
general nutrients required by MR-1 (e.g. arginine, serine,
glutamate, lactate, formate, ammonium sulfate, phos-
phate, trace metals, etc.), this should have affected growth
under all conditions. Interestingly, a porA mutant of N.
meningitidis  displayed normal growth rates, whereas a
porB mutant was somewhat retarded [34]. While N. men-
ingitidis does not have the respiratory versatility of MR-1,
these phenotypes are consistent with that of OMP35-1
and suggest that other porins may substitute for the
absence of Omp35.
While many porins exhibit heat modifiability [33,35], we
observed no such behavior for Omp35. In addition,
OMP35-1 still contained another OM protein that
migrated at 35 kDa. Another putative MR-1 porin
encoded by locus SO1420 is of similar size to Omp35.
Additional OM channel proteins, often called protein
transport pumps, allow the energy-dependent uptake or
secretion/efflux of porin-excluded substances. Transport
pumps are different than type II porins; they bind a spe-
cific substrate with a much higher affinity and their chan-
nels are not continuously open [36]. Several putative OM
uptake pumps have been identified in the genome of MR-
1. These include possible metal ion transporters and pep-
tide and/or amino acid uptake systems [37]. Omp35 is
not likely to represent one of these systems since non-
metal electron acceptors (fumarate and nitrate) were
affected in OMP35-1. Defects in amino acid uptake would
likely have affected growth under a variety of conditions.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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Amino acid sequence similarities between Omp35 of MR-1 and the top matches as identified by BLAST Figure 9
Amino acid sequence similarities between Omp35 of MR-1 and the top matches as identified by BLAST. Align-
ments were done using the ClustalW function of MacVector software. Identical residues are indicated by uppercase letters, 
analogous residues by lowercase letters, and unmatched residues by dots. Alignments were facilitated by introducing gaps (-). 
The numbers on the right indicate the relative numbering of residues within each immature protein; the total number of resi-
dues in each protein is shown in parentheses at the end of each sequence. Comparative sequences and their accession num-
bers are as follows: PorA N men (Neisseria meningitidis PorA, OM porin precursor, GenBank AF226349_1); SO1557 MR-1 (S. 
oneidensis MR-1, putative OM porin, TIGR genome locus SO1557); SO1420 MR-1 (S. oneidensis MR-1, putative OM porin, TIGR 
genome locus SO1420); IfcO S fri (S. frigidimarina, putative OM porin, GenBank AJ236923).
Omp35 MR-1      MKKTFISASVASVLALASFGALAEGP-SFYGR-LELALT---NTET   41 
PorA N men      ·K·T·l··S···l·AvA·v····E····v·GR·fqL·LT····sn·   48 
SO1557 MR-1      M····kt·····l·······A·A··P·tvYGk-Lnv···---··d-   41 
SO1420 MR-1      M·KsF···--···LAL····AvAd··-·FYGR-id··vT---·sds   39 
IfcO S fri      ··K·lIS··l·S·L·i·Sl·ALAd·P-t·YGR-Ldm·LT---NsE·   45 
Omp35 MR-1   GAT-LQSGTNGVDTKNYADENNGGTYLENNFSLLG----VKGSEKIANGY   86 
PorA N men   G····QtG---------·······s·i···iS·fG····fKGSE·l·eG·   89 
SO1557 MR-1  -----··-------------·d··T·iq·N·S·fG----VKG···l····   69 
SO1420 MR-1  G··-···-------------N··GT·LENNFS·fG----iKGS··l·d··   71 
IfcO S fri   G·T-·Q·-------------···GT·LENNFS·iG----VKGSEKI·d·f   77 
Omp35 MR-1   DVVYQMEFQVENTS-GSGD--VFKARNTFLGLKTN-AGTVLVGRNDTVFK  132 
PorA N men   ··V·QlE·dV····-G···--·w··ResFiGL··e-·Gtl··GR····F·  135 
SO1557 MR-1  ···Y·vEyQVd···-·S·D--·F·ARN·FvGLK·d-·Gs··VGRNDTllK  115 
SO1420 MR-1  ·l·YqiE··Vn··S··SGD-··F·AR·TfiGvK····G·l·VGR·D·VFK  120 
IfcO S fri   qliY·ME·Qvn··t-··GD··lF·ARNTyLGv·s·-AGTiLiGRNDTVmK  125 
Omp35 MR-1   QAEGNVDVFGNTN--ADIDRLVGAQTRSADGVWYYSPKIADLVTLNATYL  180 
PorA N men   dA···iD·····N··A····i···h······V·Y·SP···-··s····fv  184 
SO1557 MR-1  ··qGdVD·F·d··--·dl·kL···e·R·Aq···Y·tP···-···f··Tyv  162 
SO1420 MR-1  ·A·G··D···N··--···DRL···d·R··D···Y·S····-·l·L··sYL  167 
IfcO S fri   ···G·Ve·F··TN--A··nRmi··Q·R·ADGi·YYS··IA·L·TvN·TYL  173 
Omp35 MR-1   FDDNDT-------TAKTNESLYALS-ATLGDSKFKDQNYYLAVAYNKG-I  221 
PorA N men   ··qN···········K··n····L··A·vG··--··d·YY··l·Y··G··  232 
SO1557 MR-1  ·e·ND-------······q··f·v·-A··GD·KlK····Y·AlAYd··-v  203 
SO1420 MR-1  leDN··----·····r·dn··Y·L·-·T·GD··FK··d·Y·AVAY··G-v  211 
IfcO S fri   mDDN---------···s·Et·YALS-···GD··l··n·YYLA·AYN·--I  211 
Omp35 MR-1   AGIDAYRGVAQVKFGDFKVGGLFQN-SESVTNSS-----VDGNTYFVNVV  265 
PorA N men   AG··Afk······vG·······l··-Sat··e········n·q···l···  281 
SO1557 MR-1  ·G·e··R···Q·Kl··iKlGGm·Qq··qt·····-----·······V···  248 
SO1420 MR-1  ··IeAYRGV·Q·K········mlQ·-Sq·V··········eGd··iV···  260 
IfcO S fri   ·GvDAYRGV·QiKmGqFKVGGL·Q·-SES·s···-----·eGdsYFV·V·  255 
Omp35 MR-1   YTLNGVNLKAEYGVDEAGFGNYYNNVNKYTEVQIIDGKPTVVAKSTTGTD  315 
PorA N men   Y···GlNL·····lD····Gd·····N-------········A····G··  324 
SO1557 MR-1  ···-G··L·A·Y·i·-----------------------···l·······e  274 
SO1420 MR-1  Y·L··l·L·AqYG·D··G·G···N-------------r······t·····  297 
IfcO S fri   Y·LNGVNLK·EYG·DEAGFG·Y··----------··············TD  295 
Omp35 MR-1  ISVQNFNVGADYR----FSKSTMVYGQYSMYRGDH-----------VVAG  350 
PorA N men   v·······G·D··········T···········D·············l··  374 
SO1557 MR-1  ···d···VGADY·----l·K·T·Vf··Yt···---------------l··  305 
SO1420 MR-1  ··i·q··iGA·Y·----lSKST··········----------------··  327 
IfcO S fri   v·I··l··GADY·----lSKSTMl···Y·MY·G··-----------·iA·  330 
Omp35 MR-1  N--KVDLQDDNVFSVGVRYDF  369  (369 total) 
PorA N men   N····n··q·N··SVGlR··F  395  (395 total) 
SO1557 MR-1  N---·D·--D··I·iGl···F  321  (321 total) 
SO1420 MR-1  ·---·D··DD·ivSlGmRYDF  345  (345 total)
IfcO S fri   ····iDLeDDNi·tVGVRfnF  351  (351 total)BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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In addition to using Fe(III) as an electron acceptor, MR-1
must assimilate iron for cellular constituents such as
cytochromes. Siderophores are low molecular weight
Fe(III) chelators that scavenge iron from the environment
[38,39]. MR-1 synthesizes siderophores that are nega-
tively regulated by Fur (ferric uptake regulator) [40]. How-
ever, Omp35 is not likely involved in siderophore
transport for several reasons: (i) Omp35 has no homol-
ogy to known siderophore proteins; (ii) the specific cyto-
chrome content of OMP35-1 resembled that of wild-type;
(iii) the use of some electron acceptors (e.g. TMAO,
Mn(IV)) that require iron-containing components such as
cytochromes was not affected in OMP35-1; and (iv) the
growth on 10 mM Fe(III) citrate should not have invoked
a need for siderophore transport, because siderophores
are only important under low iron conditions.
A variety of genes encoding putative efflux pump proteins
have also been identified in the MR-1 genome. The
membrane fusion protein (MFP) family transports larger
molecules, such as peptides, proteins, and carbohydrates
across the OM [41]. The MR-1 genome encodes members
of this family including nine MexB-like efflux transporters
[37]. Another member of this family from E. coli is the
AcrAB efflux system [42]. A direct link to the OM by the
AcrAB efflux system occurs through TolC, an OM protein
channel that has been implicated in the secretion of pro-
teins and the efflux of toxins [43,44]. A tolC homolog has
been found to protect MR-1 from cell death due to the
accumulation of AQDS through the TolC-mediated efflux
of AQDS [45]. Although Omp35 did not match any
known OM transport pumps, the possibility of a role as an
efflux pump for the removal of toxic metabolites or the
excretion of unidentified compounds remains a possibil-
ity. A small unidentified compound that is released from
MR-1 restores the ability of a menaquinone mutant to
reduce AQDS [20]. Our results indicate that Omp35 is not
required for the secretion of this compound. Even so, a
potential role for such a compound in nitrate and fuma-
rate reduction seems improbable.
The effects of Omp35 on electron acceptor use are there-
fore likely indirect. This is also the case for MtrB, an OM
protein of MR-1 that is required for Mn(IV) and Fe(III)
reduction but that lacks obvious electron transport moie-
ties [46,47]. MtrB is required for the proper localization
and insertion of the OM cytochromes OmcA and OmcB
into the OM [47]. While the localization of OM cyto-
chromes is normal in OMP35-1, Omp35 could conceiva-
bly have a role in the localization or arrangement of OM
components required for Fe(III) reduction. How this
would also impact nitrate and fumarate reduction, how-
ever, remains unclear.
Conclusions
A 35-kDa probable porin (Omp35) was isolated from the
OM of MR-1. Omp35 levels are markedly upregulated
anaerobically by a post-transcriptional mechanism. To
our knowledge, this is the first report of a porin that is
upregulated anaerobically in this manner. An omp35 null
mutant exhibited significant lags in anaerobic growth on
fumarate, nitrate, and Fe(III). The absence of Omp35 did
not affect the quinone content or the levels or distribution
of various cytochromes in MR-1. Omp35 does not contain
obvious electron transport moieties, so its effects on the
use of electron acceptors are likely indirect. The results
highlight the possibility for non-electron transport
proteins to influence anaerobic respiratory phenotypes,
and the importance of considering such indirect effects
when characterizing electron acceptor deficiencies.
Methods
Bacterial strains, plasmids, media, and growth conditions
All materials were from sources previously described
[4,5]. A list of the bacteria and strains used in this study is
presented in Table 1. For molecular biology purposes, S.
oneidensis strains were grown aerobically at room temper-
ature (23–25°C) or at 30°C on Luria-Bertani (LB)
medium, pH 7.4 [48]. E. coli strains were grown aerobi-
cally at 37°C on LB medium. Growth media were supple-
mented with appropriate antibiotics when required,
including ampicillin (Ap), 50 µg mL-1; chloramphenicol
(Cm), 34 µg mL-1; and kanamycin (Km), 50 µg mL-1.
For other applications, S. oneidensis was grown at room
temperature either aerobically or anaerobically as
previously described [49] in M1 defined medium [2]
supplemented with 15 mM lactate and vitamin-free
Casamino Acids (0.1 g L-1). For testing the growth on or
reduction of electron acceptors under anaerobic
conditions, 15 mM formate was also included. Anaerobic
studies were conducted in an anaerobic chamber (Coy
Laboratory Products, Ann Arbor, MI) with an atmosphere
of 4 to 6% H2 (balance N2). For anaerobic growth or anal-
ysis of electron acceptor use, the medium was supple-
mented with one of the following electron acceptors: 20–
30 mM disodium fumarate, 10 mM sodium thiosulfate,
20 mM trimethylamine N-oxide (TMAO), 5 mM
dimethylsulfoxide (DMSO), or 2 mM sodium nitrate. For
growth on TMAO, the medium was also supplemented
with 30 mM HEPES to buffer against alkalinization by the
product trimethylamine. Studies with Fe(III) or Mn(IV)
were conducted in LM medium [3] supplemented with 15
mM lactate, 2 mM sodium bicarbonate, and one of the
following electron acceptors: 10 mM Fe(III) citrate, 2 mM
Fe(III) oxyhydroxide (αFeOOH), or 5 mM vernadite
(δMnO2).BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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For electron acceptor characterization of strains, inocula
were prepared from cells grown aerobically for 1–2 days
on LB medium supplemented with the appropriate antibi-
otics. Cells were suspended in sterile distilled water and
the inoculum densities were adjusted to equalize turbidity
(adjustments were made in the inoculum optical density
and/or volume).
Purification of Omp35
OM was isolated from MR-1 cells grown anaerobically
with fumarate as the electron acceptor. Loosely associated
proteins were removed by treatment of the OM at room
temperature with 23 mM sodium cholate in buffer A (20
mM K2HPO4 (pH 7.4), 1 mM EDTA, 0.02% sodium azide,
and 5% glycerol) containing 10 mM DTT (dithiothreitol)
and 0.2 M NaCl with a cholate/protein ratio of 9:1 (wt/
wt) and the protein at 1 mg mL-1. The suspension was
stirred, sonicated four times (30 sec each) with 1–2 min
periods of cooling, stirred for an additional 10 min, and
then centrifuged for 97 min at 50,000 rpm (302,000 × g)
at 4°C in a Beckman 50.2 Ti rotor. The pellets were resus-
pended in 3 mL buffer A and treated at room temperature
with lysozyme (5 × 104 U per 7–8 mg protein) for 1 hr and
with mutanolysin (6 U per mg protein) for an additional
hr to digest any remaining cell wall material. The sample
was diluted with buffer A and centrifuged as above. The
pellet was solubilized with one of the following: (i) 1.66%
Z3-12 [3-dodecyldimethylammoniopropane-1-sulfonate]
in buffer A containing 0.2 M NaCl and 10 mM DTT; (ii)
1% SDS in 50 mM Tris [hydroxymethyl]aminomethane-
HCl (pH 6.9) buffer containing 1 mM EDTA, 0.02%
sodium azide, 0.2 M NaCl, and 10 mM DTT; or (iii) 3.65
M urea plus 1.66% Z3-12 in 50 mM Tris-HCl (pH 6.9), 1
mM EDTA, 0.02% azide, 0.2 M NaCl, and 10 mM DTT.
After stirring at room temperature for 10 min, the solubi-
lized OM was sonicated twice (30 sec each with 1 min
cooling) and centrifuged for 28 min at 90,000 rpm
(438,000 × g) in a Beckman TLA-100.3 rotor at 4°C (or at
room temperature when 3.65 M urea was included).
Table 1: Bacterial strains and plasmids used in this studya
Bacterial strain or plasmid Description Reference, Source
S. oneidensis strains
MR-1 Manganese-reducing strain from Lake Oneida, N.Y. sediments [1]
OMP35-1 omp35 mutant derived from MR-1; omp35::Kmr This work
OMCA-1 omcA mutant derived from MR-1; omcA::Kmr [8]
OMCB-1 omcB mutant derived from MR-1; omcB::Kmr [8]
ETRA-153 etrA mutant derived from MR-1; etrA::Kmr [17]
CMA-1 menaquinone-minus mutant derived from MR-1 [6]
E. coli strains





S17-1λpir λ(pir) hsdR pro thi; chromosomally integrated RP4-2 Tc::Mu Km::Tn7; donor strain to mate 
pEP185.2-derived plasmids into MR-1
[62]
S17-1 C600::RP-4 2-Tc::Mu-Km::Tn7 hsdR hsdM recA thi pro; donor strain to mate pVK100- derived 
plasmids into MR-1
[62]
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15∆lacX74 deoR recA1 araD139 ∆(ara-leu)7697 galU 
galK rpsL (Smr) endA1nupG; used as host for plasmids derived from pCR2.1-TOPO
Invitrogen
Plasmidsb
pBCSK 3.4-kb vector; pUC ori; Cmr; used for complementation Stratagene
pBComp218F & R pBCSK with the MR-1 omp35 open reading frame plus associated 5' and 3' regions; 218 bp 
upstream sequence in the forward (F) and reverse (R) orientation
This work
pBComp411F & R pBCSK with the MR-1 omp35 open reading frame plus associated 5' and 3' regions; 411 bp 
upstream sequence in F and R orientation
This work
pCR2.1-TOPO 3.9-kb vector for cloning PCR products; Kmr Apr Invitrogen
pUT/mini-Tn5Km Apr; Tn5-based delivery plasmid; used as source of Kmr gene [63]
pTOPO/omp35 pCR2.1-TOPO with the MR-1 omp35 open reading frame plus associated 5' and 3' regions; 
5.6 kb
This work
pTOPO/omp35:Km pTOPO/omp35 with the Kmr gene replacing bases 458–850 of omp35; 7.3 kb This work
pEP185.2 4.28-kb mobilizable suicide vector derived from pEP184; oriR6K mobRP4 Cmr [64]
pDSEPomp35 Kmr-interrupted omp35 gene cloned into the XhoI site of pEP185.2; Cmr Kmr; 7.7 kb; used for 
gene replacement to generate strain OMP35-1
This work
aNalr, Smr, Kmr, Apr, Tcr, and Cmr, resistance to nalidixic acid, streptomycin, kanamycin, ampicillin, tetracycline, and chloramphenicol, respectively. 
bThe vector pBCSK freely replicates in MR-1 while pEP185.2 does not.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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Two methods were performed to separate Omp35 from
other OM proteins including the OM cytochromes. In the
first, Z3-12 solubilized OM was concentrated by ultrafil-
tration to a volume of < 2 mL using a Millipore Ultra-Free
filter (30,000 MWCO), and then applied to a Sephacryl S-
200 HR (Pharmacia Biotech) gel filtration column (1.6 ×
86 cm) at 4°C. Proteins were eluted with 0.5% Z3-12 in
buffer A containing 0.2 M NaCl and 10 mM DTT, and frac-
tions were screened by heme- and silver-stained SDS-
PAGE. Those containing a 35-kDa band were pooled and
dialyzed overnight in 10 mM K2HPO4 (pH 7.4) with 5%
glycerol, 1 mM EDTA, 0.02% sodium azide, 0.5% Z3-12
and 0.1 mM DTT (buffer B). The dialyzed sample was
applied to a Bio-Gel hydroxylapatite column (0.5 × 2.5
cm); after equilibration and removal of nonbinding pro-
teins with buffer B, a step gradient of increasing concen-
trations of K2HPO4 buffer was applied (25 mM, 50 mM,
100 mM, 200 mM, and 400 mM). A 35-kDa band was
prominent in the fractions which eluted at 50–100 mM
K2HPO4; this band was heme negative (i.e. not a
cytochrome).
In the second method, differential ultrafiltration was used
on OM that had been solubilized with each of the three
detergent protocols. A Pall Filtron 50,000 MWCO filter
retained the red cytochromes while the 35-kDa protein
was in the filtrate. This filtrate was concentrated using a
30,000 MWCO Millipore Ultra-Free filter, and then
applied to a GCL-300 gel filtration column (Isco, Inc; 1.6
× 35 cm). Fractions were obtained in which a 35-kDa pro-
tein was in high concentration relative to other minor
proteins.
Fractions enriched in Omp35 were subject to SDS-PAGE
and transferred to a PVDF membrane. The Omp35 band
was excised from the membrane and the N-terminal
sequence was determined by the Protein/Nucleic Acid
Shared Facility of the Medical College of Wisconsin, using
a Beckman Coulter model 2CF 3000 pulsed liquid phase
protein sequencer.
DNA manipulations
A list of synthetic oligonucleotides used is presented in
Table 2. Restriction enzyme digests, cloning, subcloning,
and DNA electrophoresis were done according to stand-
ard techniques [48] following manufacturers' recommen-
dations as appropriate. The following procedures were
done as previously reported [8,17]: DNA ligation,
isolation of plasmid and cosmid DNA, colony PCR, DNA
sequencing, and determination of sizes of DNA frag-
ments, RNA, and proteins. Electroporation and prepara-
tion of cells for electroporation was performed as
previously described for either E. coli [5] or MR-1 [17].
Computer-assisted sequence analysis and comparisons
were done with MacVector software (Accelrys, San Diego,
CA). Oligonucleotide primers were designed by using
OLIGO software (version 6.15; Molecular Biology
Insights, Cascade, CO).
Antibody specific for Omp35
Recombinant technology was used to generate a protein
fusion of thioredoxin (TR) to an internal 250-residue frag-
ment of Omp35. Specifically, a 750-bp fragment of omp35
was generated by PCR of MR-1 genomic DNA using
primers O5 and O6 (Table 2). The PCR product was
cloned into pBAD/Thio-TOPO (Invitrogen, Carlsbad,
CA), and transformed into E. coli TOP10. After identifying
a clone containing the omp35 fragment in the proper ori-
entation, expression of the fusion protein was induced
with 0.02% arabinose for 2 hr at 37°C. The cells were har-
Table 2: Synthetic oligonucleotides used in this study.
Name Oligonucleotide sequencea








Oligonucleotide based on Kmr gene
K1 5'-ATTGCGATCGATTTATGCTTGTAAACCGTT-3'
Oligonucleotides based on cat gene
C1 5'-CAGACGGCATGATGAACCTGAATC-3'
C2 5'-CCACCGTTGATATATCCCAATGGC-3'
aThe underlined regions indicate the following restriction endonuclease sites engineered into the oligonucleotides: XhoI sites in O1 and O2 and ClaI 
sites in O3, O4, and K1.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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vested by centrifugation, and lysed using Bugbuster Pro-
tein Extraction Reagent (Novagen, Madison, WI). The
resulting fusion protein, a 250-residue fragment of
Omp35 with thioredoxin (TR) at the N-terminus and a 6x
histidine tag at the C-terminus, was localized primarily in
inclusion bodies. After solubilization with 6 M urea, the
TR-Omp35 fusion was purified using His•Bind Quick
resin (Novagen) according to manufacturer's instructions.
The purified fusion was dialyzed at 4°C against 20 mM
Tris-HCl (pH7.5)/0.1 M glycine/5% (w/v) glycerol/1%
(w/v) NaCl, and then concentrated by ultrafiltration. The
purified concentrated TR-Omp35 fusion protein was used
as an antigen to generate polyclonal antisera in New Zea-
land white rabbits using Titermax (CytRx Corp., Norcross,
GA) as an adjuvant. A purified immunoglobulin G (IgG)
fraction was obtained from the immune and preimmune
sera using ammonium sulfate fractionation and ion
exchange chromatography.
Construction of an Omp35 gene replacement mutant
An omp35 gene replacement mutant (OMP35-1) was con-
structed from MR-1 using a strategy analogous to that
described previously [4]. A 1729-bp fragment containing
the entire omp35 gene plus 5' and 3' flanking sequences
was generated by PCR of MR-1 genomic DNA using cus-
tom primers O1 and O2 (Table 2). This PCR product was
cloned into pCR2.1-TOPO generating pTOPO/omp35.
Inverse PCR [50] of pTOPO/omp35 using custom primers
O3 and O4 (Table 2) generated TOPO/omp35(∆393), a
5.2-kb fragment that is missing 393 bp of internal omp35
sequence. The 2.1-kb Kmr gene from pUT/mini-Tn5Km
was generated by PCR with the custom primer K1 (Table
2). Following digestion with ClaI, the Kmr  gene was
ligated to the TOPO/omp35(∆393) fragment, generating
pTOPO/omp35:Km. A 3.4-kb DNA fragment containing
the Kmr-interrupted omp35 gene was cut from pTOPO/
omp35:Km with XhoI and ligated into the XhoI site of the
suicide vector pEP185.2, generating pDSEPomp35, which
was then electroporated into the donor strain E. coli S17-
1λpir. E. coli S17-1λpir(pDSEPomp35) was mated with
MR-1 and MR-1 exconjugants were selected using kan-
amycin under aerobic conditions on defined medium
with 15 mM lactate as the electron donor. Colonies were
screened by colony PCR [51]; those lacking the expected
wild-type 1.7 kb PCR product were pursued as putative
insertional mutants. Throughout, appropriate analyses
(restriction digests, PCR, DNA sequencing) were done to
verify that the expected constructs were obtained.
Constructs to complement OMP35-1
Wild-type omp35 plus 218 and 411 bp of upstream DNA
were amplified from MR-1 genomic DNA with custom
primers O1 and O2 (Table 2) and O1 and O7 (Table 2),
respectively, using the Expand High Fidelity PCR System
(Roche). The products were cloned in pCR2.1-TOPO,
from which the inserts were excised by either BamHI/NotI
(reverse constructs) or NotI/SacI (forward constructs) and
cloned in pBCSK generating pBComp218F and R and
pBComp411F and R. The forward construct (F) is in frame
with the lacZ promoter of the vector, whereas the reverse
(R) is in the opposite orientation. These plasmids were
electroporated into JM109, and the identity and orienta-
tion of the inserts was verified. They were then electropo-
rated into OMP35-1.
Ribonuclease protection
Total RNA was isolated from either fumarate-grown or
aerobically-grown (shaken at 200 rpm) cultures after 1
day of growth using a hot phenol method followed by
treatment with RNase-free DNase as previously described
[5,52]. To generate a probe, a 342-bp internal fragment of
omp35 was cloned into pCR2.1-TOPO; the desired orien-
tation was verified by PCR. Using M13 primers, a 585-bp
fragment containing omp35, with flanking 5' and 3' vector
DNA, was generated by PCR; using this fragment as a tem-
plate, the biotin-labeled antisense omp35 RNA probe was
generated using the MAXIscript™ Kit (Ambion) and
biotin-14-CTP. The probe was gel purified on a Tris-
borate-EDTA-urea polyacrylamide gel. RNase protection
assays were done using 10 µg total RNA, 400 pg of probe,
and the RPA III™ Kit (Ambion, Austin, TX).
Cell surface exposure studies: Proteinase K treatment of 
whole cells
MR-1 cells grown on fumarate (~40 hr) were harvested by
centrifugation (Beckman JA-14 rotor, 10 min at 10,000
rpm, 22°C) and resuspended in 10 mM HEPES, pH 7.5
(buffer H). Cell pellets were washed twice in buffer H with
50 µM MgCl2 and suspended to a final density of 45 mg
wet cell weight per mL. The cells were incubated for 15
min with proteinase K (27.5 U mL-1) or buffer as a nega-
tive control; previous time course experiments indicated
15 min was optimal for the degradation of surface-
exposed proteins. Phenylmethylsulfonyl fluoride (PMSF)
was then added (5 mM final concentration) to inhibit the
protease. The cells were pelleted (2 min at 12,000 rpm)
and washed four times in buffer containing 5 mM PMSF
(7 volumes per wash relative to the original cell suspen-
sion volume in each tube). Final pellets were resuspended
in buffer H with 50 µM MgCl2 and 5 mM PMSF, mixed
with two volumes of SDS solubilization mix [53] contain-
ing 4 M urea and 5 mM PMSF, and boiled for 10 min. The
samples were cooled to room temperature and PMSF was
added to a final concentration of 5 mM. Appropriate
dilutions were made in SDS solubilization mix containing
urea and PMSF, and then samples were immediately run
on SDS-PAGE gels. Proteinase K treatment of OM frag-
ments was done in a similar manner except no washing
steps were performed. The gels were analyzed by western
blot.BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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Flavin analysis: Fluorescence spectroscopy, thin layer 
chromatography, and UV/visible spectra
Standards of FAD and FMN were made in 0.1 M K2HPO4
(pH 7.7) buffer with 0.1 mM EDTA. Riboflavin standard
was dissolved in dimethylsulfoxide (DMSO).
For thin layer chromatography (TLC), samples were
boiled for 3 min before use. TLC was performed on Silica
GHL (Analtech) with a preabsorbant zone and developed
with 5% K2HPO4. Flavins were visualized under UV at 254
nm.
Fluorescence spectroscopy was done using a Perkin Elmer
Luminescence-LS-50B spectrometer. Samples and stand-
ards were prepared by a method modified from Faeder
and Siegel [54]. 50 µl of sample were added to 0.95 mL of
0.1 M K2HPO4 pH 7.7 with 0.1 mM EDTA (buffer S),
boiled for 3 min, and cooled rapidly to room temperature.
Alternative methods to remove non-covalent flavin from
protein samples were performed as well: (i) treatment
with 100% trichloroacetic acid (final concentration of
20%) on ice for 20 minutes before neutralization with 5
N NaOH; and (ii) chloroform extraction. Standards of
FAD and FMN (10 µM, 100 nM, 50 nM, 25 nM, 10 nM)
were made in buffer S. Fluorescence measurements were
done in 1-cm pathlength fluorometer cuvettes (excitation
at 450 nm; emission at 535 nm or a 500–580 nm scan).
Standards and samples were tested at both pH 7.7 and pH
2.6 (acidified with 0.1 mL of 1.0 N HCl). FAD and FMN
have higher fluorescence under acidic and basic condi-
tions respectively. Background fluorescence from buffer S
was subtracted from the values.
Flavin content was also analyzed by comparison of
reduced and oxidized spectra using an Aminco DW-2000
spectrophotometer operated in the split-beam mode.
Samples were used directly without boiling or other treat-
ments. Room temperature spectra were recorded in a
quartz sub-micro sample cuvette with sample and refer-
ence slit masks, using a slit width of 2.0 nm and a scan
speed of 2.0 nm s-1. To obtain reduced spectra, samples
were treated with dithionite. Scans were performed in
both the visible (400–700 nm) and UV (200–325 nm)
ranges.
The ability of OMP35-1 to restore electron acceptor use to 
a menaquinone-minus mutant
Agar plates of M1 defined medium were prepared con-
taining lactate and formate and either anthraquinone-2,6-
disulfonic acid (AQDS, 5 mM final concentration) or 10
mM Fe(III) citrate. For the former, an AQDS suspension
was prepared aseptically (0.206 g in 5 mL sterile distilled
water) and dispensed into 100 mL medium.
Inocula were grown aerobically on LB agar. Cells were sus-
pended in sterile distilled water and applied to the appro-
priate position on the agar plate using a sterile loop.
Strains were inoculated in a triangular pattern as
described by Newman and Kolter [20] with CMA-1 on 2
sides of the triangle and either MR-1 or OMP35-1 on the
third side. Plates were placed in the anaerobic chamber
immediately after inoculation. Fe(III) citrate reduction
was visualized on day 2. Agar plates were covered with a
ferrozine agarose solution (0.01 g ferrozine, 1.2% agarose
in 10 ml 50 mM HEPES, pH 7). Magenta color corre-
sponding to Fe(II)-ferrozine developed immediately.
AQDS reduction was visualized on day 3 by examining
the orange halo that formed around the streaks on the
plates; this orange color was due to the reduced product
2,6-anthrahydroquinone disulphonic acid [AHDS].
Miscellaneous procedures
For most electron acceptors, growth was assessed by meas-
uring culture turbidity at 500 nm using a Beckman DU-64
spectrophotometer. Because Fe(III) citrate interferes with
the turbidity measurement, growth on Fe(III) was
assessed by measuring total cellular protein as previously
described [3]. Nitrate [55] and nitrite [56] were deter-
mined colorimetrically in cell-free filtrates. Fe(II) was
determined by a ferrozine extraction procedure [14,57].
When Fe(III) citrate was used, Fe(II) analysis was per-
formed in unfiltered samples. When αFeOOH was used,
Fe(II) was determined in samples that were filtered
through 0.2 µm filters or that were centrifuged after ferro-
zine was added. Mn(II) was determined in filtrates by a
formaldoxime method [58,59]. δMnO2 [1] and αFeOOH
[57] were prepared as described previously.
Cytoplasmic membrane (CM), intermediate membrane
(IM), outer membrane (OM), and soluble fractions (cyto-
plasm plus periplasm) were purified by an EDTA-lys-
ozyme-Brij 58 (polyoxyethylene cetyl ether) protocol as
previously described [49]. The separation and purity of
these subcellular fractions were assessed by spectral cyto-
chrome content [49], membrane buoyant density [49],
and SDS-PAGE gels [53] stained for protein with Pro-Blue
(Owl Separation Systems, Woburn, MA) or for heme [60].
Protein was determined by a modified Lowry method,
with bovine serum albumin as the standard [5].
Quinones were extracted from cells and were resolved by
thin-layer chromatography (TLC) as previously described
[4] on Merck Kieselgel 60 F254 plates.
Western blotting was performed as previously described
and developed using either the ImmunoPure NBT/BCIP
Substrate Kit (Pierce, Inc., Rockford, IL) [16] or the Super-
Signal West Pico Kit (Pierce) [47]. Polyclonal antibodies
specific for the OM cytochromes OmcA and OmcB [9],BMC Microbiology 2004, 4:23 http://www.biomedcentral.com/1471-2180/4/23
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the OM protein MtrB [47], and the periplasmic fumarate
reductase (Fcc3) [17] have been described previously. The
antibody specific for Omp35 (above) was diluted to a
final purified IgG concentration of 0.4 µg mL-1.
Statistical analysis was performed using single-factor
ANOVA (analysis of variance). Relative band densities of
the RNA or protein blots were determined using NIH
image software http://rsb.info.nih.gov/nih-image/.
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